EQT News Alert Eqt Corp (EQT) 81.18 02/14/2015 02:28:25

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Eqt Corp (EQT) 81.18 $EQT

EQT Midstream Partners Files 2014 Annual Report
Business Wire - Thu Feb 12, 3:15PM CST
EQT Midstream Partners, LP (NYSE: EQM), an EQT Corporation company, today announced the filing of its Annual Report on Form 10-K for the fiscal year ending December 31, 2014 with the Securities and Exchange Commission (SEC). The report is available on the EQT Midstream Partners (Partnership) website at www.eqtmidstreampartners.com and on the SEC website at www.sec.gov.
EQT: 81.18 (+0.43), EQM: 88.04 (+0.96)

Pennsylvania governor proposes new tax on nat gas extraction
Seeking Alpha - at Seeking Alpha - Thu Feb 12, 10:33AM CST

AR: 40.34 (+0.69), CNX: 33.60 (+0.87), WPX: 12.60 (-0.04), TLM: 7.63 (-0.03), ATLS: 30.17 (+0.27), XOM: 93.37 (+1.00), RRC: 50.84 (+0.07), EQT: 81.18 (+0.43), RDS.B: 69.26 (+0.86), RDS.A: 66.32 (+0.97), COG: 28.10 (+0.18), CHK: 21.08 (+0.58), EOG: 96.92 (+2.12), XCO: 2.52 (+0.20), CRZO: 52.60 (+1.17), CVX: 112.78 (+1.92), SWN: 27.36 (+0.51), APC: 89.44 (+2.13)

Top IPO Stocks: EQM Midstream Insulated From Slide
at Investor's Business Daily - Wed Feb 11, 4:50PM CST
While energy stocks have been pummeled, shares of pipeline operator EQT Midstream Partners (EQM) have been far more steady. The company last week reported Q4 earnings that topped Wall Street's expectations. Profit of $1.12 a share marked an 81%...
EQT: 81.18 (+0.43), EQM: 88.04 (+0.96)

Look for Shares of EQT to Potentially Pullback after Yesterday's 1.24% Rise
Comtex SmarTrend(R) - Mon Feb 09, 4:20PM CST
EQT (NYSE:EQT) traded in a range yesterday that spanned from a low of $78.68 to a high of $80.52. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $79.82 on volume of 2.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
EQT: 81.18 (+0.43)

Watch for EQT to Potentially Pullback After Gaining 1.24% Yesterday
Comtex SmarTrend(R) - Mon Feb 09, 4:20PM CST
EQT (NYSE:EQT) traded in a range yesterday that spanned from a low of $78.68 to a high of $80.52. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $79.82 on volume of 2.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
EQT: 81.18 (+0.43)

EQT Corporation: Understanding Marcellus Economics
Richard Zeits - at Seeking Alpha - Mon Feb 09, 2:00PM CST

EQT: 81.18 (+0.43)

Equitas Resources Announces Non-Brokered Private Placement and Proposed Shares for Debt Settlement
CNW Group - Fri Feb 06, 7:30AM CST
Equitas Resources Corp. (TSXv: EQT) (FSE: T6U1) ("Equitas" or the "Company" announces, subject to TSX Venture Exchange ("Exchange" acceptance, a non-brokered private placement of 5,257,240 units ("Units" at a price of $0.05 per Unit for gross proceeds of $262,862. Each Unit will consist of one common share and one Warrant. Each Warrant is exercisable into one common share of the Company for a period of 24 months from closing at a price of $0.10 per common share.
EQT: 81.18 (+0.43), EQT.VN: 0.095 (+0.005)

EQT (EQT) Earnings Report: Q4 2014 Conference Call Transcript
at The Street - Thu Feb 05, 6:32PM CST
The following EQT (EQT) conference call took place on February 5, 2015, 10:30 AM ET. This is a transcript of that earnings call:
EQT: 81.18 (+0.43)

EQT (EQT) Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Feb 05, 2:30PM CST

EQT: 81.18 (+0.43)

EQT Down 13.7% Since SmarTrend Downtrend Call (EQT)
Comtex SmarTrend(R) - Thu Feb 05, 9:54AM CST
SmarTrend identified a Downtrend for EQT (NYSE:EQT) on November 28th, 2014 at $90.80. In approximately 2 months, EQT has returned 13.71% as of today's recent price of $78.35.
EQT: 81.18 (+0.43)

EQT Corp Surpasses Q4 Earnings and Revenue Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 05, 9:30AM CST
EQT Corporation's (EQT) fourth-quarter 2014 adjusted earnings increased 146% year over year to 96 cents per share and beat the Zacks Consensus Estimate of 69 cents.
EQT: 81.18 (+0.43), GMLP: 28.17 (+0.45), IOC: 47.68 (+0.60), CSIQ: 28.84 (-0.30)

Be on Top of the Latest Happenings: Special Research on Forum Energy, ENSCO, EOG Resources, EP Energy, and EQT Corp.
PR Newswire - Thu Feb 05, 8:20AM CST
Moments ago, Analysts Review released new research updates concerning several important developing situations including Forum Energy (NYSE: FET), ENSCO (NYSE: ESV), EOG Resources (NYSE: EOG), EP Energy (NYSE: EPE), and EQT Corp (NYSE: EQT). Analysts Review provides a single unified platform for investors' to hear about what matters - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.
EQT: 81.18 (+0.43), ESV: 30.03 (+0.41), EOG: 96.92 (+2.12), EPE: 12.90 (+0.56), FET: 18.70 (+2.61)

EQT Corporation (EQT) Shares Beats on Q4 Earnings & Revenues - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Feb 05, 7:36AM CST
EQT Corporation (EQT) Shares Beats on Q4 Earnings & Revenues
EQT: 81.18 (+0.43)

EQT beats by $0.32, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Feb 05, 6:05AM CST

EQT: 81.18 (+0.43)

EQT Midstream Partners Reports 2014 Results
Business Wire - Thu Feb 05, 6:04AM CST
EQT Midstream Partners, LP (NYSE: EQM), an EQT Corporation (EQT) company, today announced full-year and fourth quarter 2014 financial and operating results. For the year, net income totaled $232.8 million, while adjusted EBITDA was $255.6 million and distributable cash flow was $229.5 million. Net income for the quarter totaled $74.7 million and adjusted EBITDA was $85.9 million. Distributable cash flow was $76.2 million for the quarter. Adjusted operating income was $78.3 million, or 39% higher than the same quarter in 2013. The non-GAAP financial measures are reconciled in the Non-GAAP Disclosures section of this news release.
EQT: 81.18 (+0.43), EQM: 88.04 (+0.96)

EQT Proved Reserves Increase 29% to 10.7 Tcfe
Business Wire - Thu Feb 05, 6:02AM CST
EQT Corporation (NYSE: EQT) today reported year-end 2014 total proved reserves of 10.7 Tcfe. This represents a 2.4 Tcfe net increase over 2013, with a reserve replacement ratio of 590%.
EQT: 81.18 (+0.43)

EQT Reports Year-End 2014 Earnings
Business Wire - Thu Feb 05, 6:01AM CST
EQT Corporation (NYSE: EQT) today announced 2014 net income attributable to EQT of $387.0 million, or $2.54 per diluted share (EPS), comparable to the 2013 earnings of $390.6 million, or $2.57 per diluted share. To better compare year-over-year earnings, several items should be considered, including $188.3 million of after-tax impairment charges recorded on the Company's Ohio Utica and Texas Permian assets in the fourth quarter that negatively impacted 2014 results; and earnings attributable to EQT's sold distribution business, that positively impacted 2013 results. Adjusted net income was $518.6 million in 2014, 74% higher than the $298.7 million in 2013; while 2014 adjusted EPS was $3.40. Adjusted operating cash flow attributable to EQT was $1,424.0 million in 2014, 19% higher. The non-GAAP financial measures are detailed and reconciled in the Non-GAAP Disclosures section in this news release.
EQT: 81.18 (+0.43), EQM: 88.04 (+0.96)

Notable earnings before Thursday’s open
Seeking Alpha - at Seeking Alpha - Wed Feb 04, 4:30PM CST

FIS: 66.52 (+0.33), PRGO: 150.90 (+0.22), LAZ: 50.90 (+0.18), CHTR: 177.88 (+0.85), LQDT: 9.52 (+0.09), CFX: 52.02 (+3.84), KORS: 73.27 (+1.72), OZM: 11.93 (-0.14), PTEN: 18.14 (+1.13), DLPH: 78.70 (+0.64), DNKN: 46.70 (-0.69), DFT: 31.83 (-0.17), AMSC: 0.80 (+0.02), APO: 23.70 (+0.36), SNCR: 43.89 (+1.06), PRLB: 74.00 (+2.60), CSL: 94.14 (-0.09), SIRI: 3.83 (-0.07), PBH: 39.07 (+0.27), COTY: 22.03 (unch), RSTI: 24.12 (+0.20), IT: 81.53 (+1.64), ADS: 286.61 (+1.70), AINV: 7.71 (+0.15), AZN: 69.96 (+0.20), BCE: 44.74 (+0.14), NGD: 3.73 (-0.04), EL: 82.49 (+1.58), BCO: 25.73 (+0.18), RFP: 19.03 (+0.40), ODFL: 76.25 (+0.96), BDX: 143.71 (+0.72), GRA: 101.61 (+1.69), SNA: 145.40 (+0.71), BR: 52.59 (-0.29), BLL: 74.93 (+0.89), GRUB: 39.93 (+1.71), SBH: 33.10 (+0.28), ARW: 61.98 (+0.78), ETR: 79.12 (-1.53), BDC: 87.78 (+0.61), IVC: 17.13 (+0.15), CMI: 139.04 (+2.41), S: 5.23 (+0.08), PPL: 34.69 (-0.16), NUS: 56.92 (-1.30), MMP: 80.41 (-0.86), MMS: 59.14 (+0.12), MSCI: 57.20 (unch), MDSO: 46.58 (+1.48), ICE: 233.22 (-1.21), FBP: 6.35 (-0.02), LIOX: 5.57 (+0.10), CI: 114.47 (-0.51), PM: 82.87 (-0.82), EQT: 81.18 (+0.43), GPI: 84.34 (-0.74), ABB: 21.34 (+0.27), GPK: 15.41 (+0.29), GLT: 24.89 (+0.04), EQM: 88.04 (+0.96)

Equitas Resources Corp. Announces Commencement of Initial Exploration Program on the Garland Project and Management Additions
CNW Group - Tue Feb 03, 3:00PM CST
Equitas Resources Corp. (TSXv: EQT) (FSE: T6UN) ("Equitas" or the "Company" is pleased to announce that it has commenced its nickel exploration program on the Garland Property in Labrador, Canada which is located less than 30kms south-east of the Voisey's Bay Mine. The work will encompass a VTEM survey with a follow-up field program.
EQT: 81.18 (+0.43), EQT.VN: 0.095 (+0.005)

Why Should You Buy EQT Corporation?
Investing Tricks - at Seeking Alpha - Tue Feb 03, 8:18AM CST

EQT: 81.18 (+0.43)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Weifang's Cultural Resurgence: A Global Epigraphy Fest

Updated Category News Views 44

A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...

Continue Reading
Masimo's smartSET™ Revolutionizes Patient Monitoring

Updated Category News Views 44

Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...

Continue Reading
Innventure Faces Major Lawsuit Over Misleading Investors

Updated Category News Views 61

Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...

Continue Reading
Voter Events by Valley Community Healthcare Aim to Empower

Updated Category News Views 38

Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....

Continue Reading
Hyliion Class Action Deadline Nears for Investors

Updated Category News Views 56

Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...

Continue Reading
AEVEX Facing Class Action Deadline Amid Stock Turmoil

Updated Category News Views 46

Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...

Continue Reading
LG OLED evo W6: UAE Roadshow Starts with a Bang

Updated Category News Views 48

They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...

Continue Reading

Top 5 Most Recently Viewed Articles

Cemtrex's Stock Surge Sparks Interest in Leading Movers

Updated Category News Views 117

Cemtrex Experiences Notable Share Surge Shares of Cemtrex, Inc. CETX have seen a significant uptick amid pre-market trading. This boost comes on the heels of better-than-expected sales in the latest quarter, reporting an impressive $18.10 million in sales, surpassing the general analyst expectation of $16.39 million. This remarkable performance in sales has sparked...

Continue Reading
Exciting New PharmD-MBA Pathway Combines Pharmacy and Business

Updated Category News Views 193

Collaboration between Cal Poly Pomona and Western University In an exciting move, Cal Poly Pomona's Singelyn Graduate School of Business and Western University of Health Sciences have teamed up to create a groundbreaking pathway for aspiring healthcare professionals. This innovative PharmD-MBA program combines the fields of pharmacy and business, providing a unique...

Continue Reading
Kaskela Law Investigates Stock Misconduct in Stanley Black & Decker

Updated Category News Views 155

Overview of the Investigation by Kaskela Law LLC Kaskela Law LLC has announced an important investigation focused on Stanley Black & Decker, Inc. (NYSE: SWK) concerning allegations of potential securities fraud. This inquiry is primarily aimed at safeguarding the interests of long-term investors who hold shares in this well-known manufacturing company. Details Surrounding...

Continue Reading
Legend Biotech's Carvykti: A Leading Force in Cancer Treatment

Updated Category News Views 90

Redburn's Positive Outlook for Legend Biotech Recently, Redburn-Atlantic began covering Legend Biotech Corp. (NASDAQ: LEGN) with a favorable Buy rating and set a price target of $86.00 for the stock. This biotechnology company has made significant strides, particularly with the recent approval of its innovative product, Carvykti, designed for the treatment of multiple...

Continue Reading
Transforming the Anti-Obesity Drug Market for Future Success

Updated Category News Views 132

Global Anti-Obesity Drug Market Overview As global health concerns rise, the demand for anti-obesity drugs is surging. Recent reports estimate that the anti-obesity drug market will soar to USD 82.55 billion in the coming years. This impressive growth, fueled by an anticipated compound annual growth rate (CAGR) of 18.01%, signals a crucial moment for pharmaceutical...

Continue Reading